Self-Guided Personalized Treatment for Women
Study Details
Study Description
Brief Summary
The investigators plan to collect preliminary data on the feasibility, acceptability, and user uptake of a personalized self-guided mobile intervention for disordered eating (DE) and test the initial clinical efficacy of this intervention. Women (N=50) who endorse significant DE will complete two weeks of smart-phone self-monitoring to identify target problems and will be sent two self-guided modules of personalized treatment directly to their smart-phones. The investigators will assess engagement with the modules throughout two months and administer baseline, week 5, and week 8 assessments for acceptability, uptake, and initial clinical efficacy (e.g., DE symptoms, anxiety, quality of life). The investigators will also complete a focus group (n=10) with a subset of users to receive input on the mobile-application assessment and ease of self-guided intervention modules.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Self-guided Personalized Treatment Women who endorse significant DE will complete two weeks of smart-phone self-monitoring to identify target problems and will be sent two self-guided modules of personalized treatment directly to their smart-phones. |
Behavioral: Self-guided Personalized Treatment
Women who endorse significant DE will complete two weeks of smart-phone self-monitoring to identify target problems and will be sent two self-guided modules of personalized treatment directly to their smart-phones.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Disordered eating symptoms [Up to 8 weeks]
Changes in disordered eating symptoms will be assessed with the Eating Disorder Examination Questionnaire-6 (EDE-Q6)
- Anxiety [Up to 8 weeks]
Changes in anxiety will be assessed with the Penn State Worry Questionnaire (PSWQ)
- Depression [Up to 8 weeks]
Changes in depression will be assessed with the Beck Depression Inventory-2 (BDI-2)
- Clinical Impairment [Up to 8 weeks]
Changes in clinical impairment will be assessed with the Clinical Impairment Assessment (CIA)
- Quality of life [Up to 8 weeks]
Changes in quality of life will be assessed with the Quality of Life Scale (QOLS)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Endorse disordered eating (score of 2.3 or above on EDE-Q6)
-
Age 18-65
-
Ability to read and write English
-
Own a smartphone or tablet
Exclusion Criteria:
-
Active mania
-
Active suicidality
-
Active psychosis
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Eating Anxiety Treatment Laboratory and Clinic | Louisville | Kentucky | United States | 40205-1016 |
Sponsors and Collaborators
- University of Louisville
- National Institute of Mental Health (NIMH)
Investigators
- Principal Investigator: Cheri A Levinson, University of Louisville
Study Documents (Full-Text)
None provided.More Information
Publications
- Borsboom D, Cramer AO. Network analysis: an integrative approach to the structure of psychopathology. Annu Rev Clin Psychol. 2013;9:91-121. doi: 10.1146/annurev-clinpsy-050212-185608.
- Levinson CA, Hunt RA, Keshishian AC, Brown ML, Vanzhula I, Christian C, Brosof LC, Williams BM. Using individual networks to identify treatment targets for eating disorder treatment: a proof-of-concept study and initial data. J Eat Disord. 2021 Nov 4;9(1):147. doi: 10.1186/s40337-021-00504-7. Erratum In: J Eat Disord. 2022 Jul 11;10(1):99.
- Levinson CA, Williams BM, Christian C, Hunt RA, Keshishian AC, Brosof LC, Vanzhula IA, Davis GG, Brown ML, Bridges-Curry Z, Sandoval-Araujo LE, Ralph-Nearman C. Personalizing eating disorder treatment using idiographic models: An open series trial. J Consult Clin Psychol. 2023 Jan;91(1):14-28. doi: 10.1037/ccp0000785.
- IRB#23.0274